Digestase 2.0™

AOR08302

Vegan digestive enzymes*

  • The first research-based digestive enzyme formula
  • Vegan formula providing seven types of digestive enzymes
  • Helps digest protein, fats, fiber, starches, legumes, and lactose
Gluten Free
Non-GMO
Vegan Society

$39.96 or subscribe and get 20% off

In stock

Choose a subscription plan:

Digestase 2.0™ is a vegan supplement containing a mixture of seven types of digestive enzymes from a variety of sources that guarantees function at different pH ranges. The formula helps improve digestion and nutrient absorption while reducing gas and bloating caused by hard-to-digest foods.

While indigestion is not a disease and individuals experience it in different ways, it is discomfort that can be alleviated. This is where digestive enzymes, biological molecules that are made by our body’s organs, come into play. Because our bodies require the help of many different enzymes to digest the foods we consume, using an enzyme supplement can help with digestion, promote the health of the gastrointestinal system, enhance nutrient absorption, and alleviate the gastrointestinal burdens of digesting some foods.

AOR Advantage

AOR’s Digestase 2.0™ formula is a premium solution that combines two sources of proteases and lipases to ensure the broadest possible range of enzymatic activity because protease and lipase enzymes operate under varying pH levels within the digestive tract. Digestase 2.0™ is an ideal solution for those who experience digestive discomfort and are looking to improve their gastrointestinal health.

Discussion

Digestase 2.0™ is a comprehensive vegan enzyme formula with proteases and lipases for digestive tract health.*

Guarantees

AOR™ guarantees that all ingredients have been declared on the label. Made without wheat, gluten, peanuts, sesame seeds, sulfites, mustard, soy, dairy, eggs or any animal byproduct.

Directions

Take one capsule three times daily with food, or as directed by a qualified health care practitioner.

Cautions

Do not use if you are pregnant or lactating. Consult a health care practitioner if you have any other medical condition, or if you’re taking any medication. Keep out of reach of children.

Disclaimer

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Serving Size: One Capsule / Servings Per Container: 90
Per Capsule
Per Day (Three Capsules)
Amount Per Serving
% Daily Value
% Daily Value
Amylase (from Aspergillus oryzae)
75 mg (3,000 DU)
225 mg (9,000 DU)
Protease (from A. oryzae)
40.4 mg (20,200 HUT)
121 mg (60,600 HUT)
Lactase (from A. oryzae)
30 mg (3,000 ALU)
90 mg (9,000 ALU)
Lipase (from A. niger and Rhizopus oryzae)
12.5 mg (250 LU)
38 mg (750 LU)
Protease (from Aspergillus niger)
9.4 mg (10.1 SAP)
28 mg (30 SAP)
Alpha Galactosidase (from A. niger)
8.7 mg (86.7 GalU)
26 mg (260 GalU)
Cellulase (from A. niger)
8 mg (600 CU
24 mg (1,800 CU)
Invertase (from Saccharomyces cerevisiae)
4 mg (400 SU)
12 mg (1,200 SU)

† Daily Value not established.

Other Ingredients: microcrystalline cellulose, maltodextrin, tapioca and potato dextrin, d-mannitol, sodium chloride, calcium gluconate and sodium stearyl fumarate.

Capsule: hypromellose and purified water.

Layer P, Keller J. Lipase supplementation therapy: standards, alternatives, and perspectives. Pancreas. 2003 Jan;26(1):1-7. Review.

Lomax E. The use of oral proteolytic enzymes in the post-lipoplasty patient. Case report (unpublished)

Meng X, Slominski BA, Guenter W. The effect of fat type, carbohydrase, and lipase addition on growth performance and nutrient utilization of young broilers fed wheat-based diets. Poult Sci. 2004 Oct;83(10):1718-27.

Miller PC, Bailey SP, Barnes ME, Derr SJ, Hall EE. The effects of protease supplementation on skeletal muscle function and DOMS following downhill running. J Sports Sci. 2004 Apr;22(4):365-72.

Ritz CW, Hulet RM, Self BB, Denbow DM. Growth and intestinal morphology of male turkeys as influenced by dietary supplementation of amylase and xylanase. Poult Sci. 1995 Aug;74(8):1329-34.

Zeijdner E, Havenaar R, (2000). The Fate of orally administered compounds during passage through the gastrointestinal tract simulated in a dynamic in vitro model (TIM). European pharmaceutical Contractor, Febr. Isue: 76-81

Zeijdner E, Mohede R, I.C.M. (1999). Latest tool for screening new clinical foods. A dynamic, computer-controlled model of the human gastrointestinal tract is the most up-to-date technology for testing new foods. New World Health 199-2000: 105.a

Please select a start rating
{{review.user_complete_name}}
{{review.date | date:'medium'}}
{{review.comment}}
Comment pending for approval
Reply
{{child.user_complete_name}}
{{child.date | date:'medium'}}
{{child.comment}}
Comment pending for approval
Reply
{{child2.user_complete_name}}
{{child2.date | date:'medium'}}
{{child2.comment}}
Comment pending for approval
Reply